Postoperative radiotherapy in prostate cancer: When and how?  - An update review
Cancer Radiother. 2022 Apr 12:S1278-3218(22)00003-8. doi: 10.1016/j.canrad.2021.10.009. Online ahead of print.ABSTRACTRadical prostatectomy (RP) has been found to be curative in most cases of prostate cancer (PCa); however, 20-40% of patients have a biochemical recurrence (BCR) of the disease. Prostatic specific antigen prostate-specific antigen (PSA) levels are used to assess patient prognosis after surgery; however, there is no consensus about the optimal PSA level that defines BCR. Detection of very low volume disease and early detection of the disease are very important predictors for clinical outcomes in BCR, as early...
Source: Cancer Radiotherapie - April 16, 2022 Category: Cancer & Oncology Authors: R N Asso F A M Degrande J L Fernandes da Silva E T T Leite Source Type: research

Postoperative radiotherapy in prostate cancer: When and how?  - An update review
Cancer Radiother. 2022 Apr 12:S1278-3218(22)00003-8. doi: 10.1016/j.canrad.2021.10.009. Online ahead of print.ABSTRACTRadical prostatectomy (RP) has been found to be curative in most cases of prostate cancer (PCa); however, 20-40% of patients have a biochemical recurrence (BCR) of the disease. Prostatic specific antigen prostate-specific antigen (PSA) levels are used to assess patient prognosis after surgery; however, there is no consensus about the optimal PSA level that defines BCR. Detection of very low volume disease and early detection of the disease are very important predictors for clinical outcomes in BCR, as early...
Source: Cancer Radiotherapie - April 16, 2022 Category: Cancer & Oncology Authors: R N Asso F A M Degrande J L Fernandes da Silva E T T Leite Source Type: research

Postoperative radiotherapy in prostate cancer: When and how?  - An update review
Cancer Radiother. 2022 Apr 12:S1278-3218(22)00003-8. doi: 10.1016/j.canrad.2021.10.009. Online ahead of print.ABSTRACTRadical prostatectomy (RP) has been found to be curative in most cases of prostate cancer (PCa); however, 20-40% of patients have a biochemical recurrence (BCR) of the disease. Prostatic specific antigen prostate-specific antigen (PSA) levels are used to assess patient prognosis after surgery; however, there is no consensus about the optimal PSA level that defines BCR. Detection of very low volume disease and early detection of the disease are very important predictors for clinical outcomes in BCR, as early...
Source: Cancer Radiotherapie - April 16, 2022 Category: Cancer & Oncology Authors: R N Asso F A M Degrande J L Fernandes da Silva E T T Leite Source Type: research

Postoperative radiotherapy in prostate cancer: When and how?  - An update review
Cancer Radiother. 2022 Apr 12:S1278-3218(22)00003-8. doi: 10.1016/j.canrad.2021.10.009. Online ahead of print.ABSTRACTRadical prostatectomy (RP) has been found to be curative in most cases of prostate cancer (PCa); however, 20-40% of patients have a biochemical recurrence (BCR) of the disease. Prostatic specific antigen prostate-specific antigen (PSA) levels are used to assess patient prognosis after surgery; however, there is no consensus about the optimal PSA level that defines BCR. Detection of very low volume disease and early detection of the disease are very important predictors for clinical outcomes in BCR, as early...
Source: Cancer Radiotherapie - April 16, 2022 Category: Cancer & Oncology Authors: R N Asso F A M Degrande J L Fernandes da Silva E T T Leite Source Type: research

Postoperative radiotherapy in prostate cancer: When and how?  - An update review
Cancer Radiother. 2022 Apr 12:S1278-3218(22)00003-8. doi: 10.1016/j.canrad.2021.10.009. Online ahead of print.ABSTRACTRadical prostatectomy (RP) has been found to be curative in most cases of prostate cancer (PCa); however, 20-40% of patients have a biochemical recurrence (BCR) of the disease. Prostatic specific antigen prostate-specific antigen (PSA) levels are used to assess patient prognosis after surgery; however, there is no consensus about the optimal PSA level that defines BCR. Detection of very low volume disease and early detection of the disease are very important predictors for clinical outcomes in BCR, as early...
Source: Cancer Radiotherapie - April 16, 2022 Category: Cancer & Oncology Authors: R N Asso F A M Degrande J L Fernandes da Silva E T T Leite Source Type: research

Postoperative radiotherapy in prostate cancer: When and how?  - An update review
Cancer Radiother. 2022 Apr 12:S1278-3218(22)00003-8. doi: 10.1016/j.canrad.2021.10.009. Online ahead of print.ABSTRACTRadical prostatectomy (RP) has been found to be curative in most cases of prostate cancer (PCa); however, 20-40% of patients have a biochemical recurrence (BCR) of the disease. Prostatic specific antigen prostate-specific antigen (PSA) levels are used to assess patient prognosis after surgery; however, there is no consensus about the optimal PSA level that defines BCR. Detection of very low volume disease and early detection of the disease are very important predictors for clinical outcomes in BCR, as early...
Source: Cancer Radiotherapie - April 16, 2022 Category: Cancer & Oncology Authors: R N Asso F A M Degrande J L Fernandes da Silva E T T Leite Source Type: research

Postoperative radiotherapy in prostate cancer: When and how?  - An update review
Cancer Radiother. 2022 Apr 12:S1278-3218(22)00003-8. doi: 10.1016/j.canrad.2021.10.009. Online ahead of print.ABSTRACTRadical prostatectomy (RP) has been found to be curative in most cases of prostate cancer (PCa); however, 20-40% of patients have a biochemical recurrence (BCR) of the disease. Prostatic specific antigen prostate-specific antigen (PSA) levels are used to assess patient prognosis after surgery; however, there is no consensus about the optimal PSA level that defines BCR. Detection of very low volume disease and early detection of the disease are very important predictors for clinical outcomes in BCR, as early...
Source: Cancer Radiotherapie - April 16, 2022 Category: Cancer & Oncology Authors: R N Asso F A M Degrande J L Fernandes da Silva E T T Leite Source Type: research

Postoperative radiotherapy in prostate cancer: When and how?  - An update review
Cancer Radiother. 2022 Apr 12:S1278-3218(22)00003-8. doi: 10.1016/j.canrad.2021.10.009. Online ahead of print.ABSTRACTRadical prostatectomy (RP) has been found to be curative in most cases of prostate cancer (PCa); however, 20-40% of patients have a biochemical recurrence (BCR) of the disease. Prostatic specific antigen prostate-specific antigen (PSA) levels are used to assess patient prognosis after surgery; however, there is no consensus about the optimal PSA level that defines BCR. Detection of very low volume disease and early detection of the disease are very important predictors for clinical outcomes in BCR, as early...
Source: Cancer Radiotherapie - April 16, 2022 Category: Cancer & Oncology Authors: R N Asso F A M Degrande J L Fernandes da Silva E T T Leite Source Type: research

Postoperative radiotherapy in prostate cancer: When and how?  - An update review
Cancer Radiother. 2022 Apr 12:S1278-3218(22)00003-8. doi: 10.1016/j.canrad.2021.10.009. Online ahead of print.ABSTRACTRadical prostatectomy (RP) has been found to be curative in most cases of prostate cancer (PCa); however, 20-40% of patients have a biochemical recurrence (BCR) of the disease. Prostatic specific antigen prostate-specific antigen (PSA) levels are used to assess patient prognosis after surgery; however, there is no consensus about the optimal PSA level that defines BCR. Detection of very low volume disease and early detection of the disease are very important predictors for clinical outcomes in BCR, as early...
Source: Cancer Radiotherapie - April 16, 2022 Category: Cancer & Oncology Authors: R N Asso F A M Degrande J L Fernandes da Silva E T T Leite Source Type: research

Postoperative radiotherapy in prostate cancer: When and how?  - An update review
Cancer Radiother. 2022 Apr 12:S1278-3218(22)00003-8. doi: 10.1016/j.canrad.2021.10.009. Online ahead of print.ABSTRACTRadical prostatectomy (RP) has been found to be curative in most cases of prostate cancer (PCa); however, 20-40% of patients have a biochemical recurrence (BCR) of the disease. Prostatic specific antigen prostate-specific antigen (PSA) levels are used to assess patient prognosis after surgery; however, there is no consensus about the optimal PSA level that defines BCR. Detection of very low volume disease and early detection of the disease are very important predictors for clinical outcomes in BCR, as early...
Source: Cancer Radiotherapie - April 16, 2022 Category: Cancer & Oncology Authors: R N Asso F A M Degrande J L Fernandes da Silva E T T Leite Source Type: research

Postoperative radiotherapy in prostate cancer: When and how?  - An update review
Cancer Radiother. 2022 Apr 12:S1278-3218(22)00003-8. doi: 10.1016/j.canrad.2021.10.009. Online ahead of print.ABSTRACTRadical prostatectomy (RP) has been found to be curative in most cases of prostate cancer (PCa); however, 20-40% of patients have a biochemical recurrence (BCR) of the disease. Prostatic specific antigen prostate-specific antigen (PSA) levels are used to assess patient prognosis after surgery; however, there is no consensus about the optimal PSA level that defines BCR. Detection of very low volume disease and early detection of the disease are very important predictors for clinical outcomes in BCR, as early...
Source: Cancer Radiotherapie - April 16, 2022 Category: Cancer & Oncology Authors: R N Asso F A M Degrande J L Fernandes da Silva E T T Leite Source Type: research

Postoperative radiotherapy in prostate cancer: When and how?  - An update review
Cancer Radiother. 2022 Apr 12:S1278-3218(22)00003-8. doi: 10.1016/j.canrad.2021.10.009. Online ahead of print.ABSTRACTRadical prostatectomy (RP) has been found to be curative in most cases of prostate cancer (PCa); however, 20-40% of patients have a biochemical recurrence (BCR) of the disease. Prostatic specific antigen prostate-specific antigen (PSA) levels are used to assess patient prognosis after surgery; however, there is no consensus about the optimal PSA level that defines BCR. Detection of very low volume disease and early detection of the disease are very important predictors for clinical outcomes in BCR, as early...
Source: Cancer Radiotherapie - April 16, 2022 Category: Cancer & Oncology Authors: R N Asso F A M Degrande J L Fernandes da Silva E T T Leite Source Type: research

Postoperative radiotherapy in prostate cancer: When and how?  - An update review
Cancer Radiother. 2022 Apr 12:S1278-3218(22)00003-8. doi: 10.1016/j.canrad.2021.10.009. Online ahead of print.ABSTRACTRadical prostatectomy (RP) has been found to be curative in most cases of prostate cancer (PCa); however, 20-40% of patients have a biochemical recurrence (BCR) of the disease. Prostatic specific antigen prostate-specific antigen (PSA) levels are used to assess patient prognosis after surgery; however, there is no consensus about the optimal PSA level that defines BCR. Detection of very low volume disease and early detection of the disease are very important predictors for clinical outcomes in BCR, as early...
Source: Cancer Radiotherapie - April 16, 2022 Category: Cancer & Oncology Authors: R N Asso F A M Degrande J L Fernandes da Silva E T T Leite Source Type: research

Postoperative radiotherapy in prostate cancer: When and how?  - An update review
Cancer Radiother. 2022 Apr 12:S1278-3218(22)00003-8. doi: 10.1016/j.canrad.2021.10.009. Online ahead of print.ABSTRACTRadical prostatectomy (RP) has been found to be curative in most cases of prostate cancer (PCa); however, 20-40% of patients have a biochemical recurrence (BCR) of the disease. Prostatic specific antigen prostate-specific antigen (PSA) levels are used to assess patient prognosis after surgery; however, there is no consensus about the optimal PSA level that defines BCR. Detection of very low volume disease and early detection of the disease are very important predictors for clinical outcomes in BCR, as early...
Source: Cancer Radiotherapie - April 16, 2022 Category: Cancer & Oncology Authors: R N Asso F A M Degrande J L Fernandes da Silva E T T Leite Source Type: research

Postoperative radiotherapy in prostate cancer: When and how?  - An update review
Cancer Radiother. 2022 Apr 12:S1278-3218(22)00003-8. doi: 10.1016/j.canrad.2021.10.009. Online ahead of print.ABSTRACTRadical prostatectomy (RP) has been found to be curative in most cases of prostate cancer (PCa); however, 20-40% of patients have a biochemical recurrence (BCR) of the disease. Prostatic specific antigen prostate-specific antigen (PSA) levels are used to assess patient prognosis after surgery; however, there is no consensus about the optimal PSA level that defines BCR. Detection of very low volume disease and early detection of the disease are very important predictors for clinical outcomes in BCR, as early...
Source: Cancer Radiotherapie - April 16, 2022 Category: Cancer & Oncology Authors: R N Asso F A M Degrande J L Fernandes da Silva E T T Leite Source Type: research